Psilocybin For Cancer Related Distress: Enveric To Launch Clinical Trial In Partnership With University of Calgary
Enveric Biosciences (NASDAQ: ENVB) a neuroscience company developing psychedelics and cannabinoids into mental health medicines, announced a collaboration with the University of Calgary’s Hotchkiss Brain Institute.
78 Biggest Movers From Friday
Gainers
Y-mAbs Therapeutics, Inc. (NASDAQ: YMAB) surged 26% to close at $2.24. Y-mAbs reported completion of pre-BLA meeting with the FDA for Omburtamab.
12 Health Care Stocks Moving In Friday’s After-Market Session
Gainers
Avenue Therapeutics (NASDAQ:ATXI) stock moved upwards by 17.2% to $0.7 during Friday's after-market session. The company's market cap stands at $14.5 million.
Mid-Day Market Update: Nasdaq Drops 100 Points; Bloom Energy Shares Jump
The Nasdaq turned lower during the mid-day session, with the tech-laden index falling 100 points on Friday.
41 Stocks Moving In Friday’s Mid-Day Session
Gainers
Modular Medical, Inc. (NASDAQ: MODD) shares climbed 34.5% to $4.99 following its recent uplisting to the Nasdaq Capital Market on Thursday.
Enveric Biosciences Shares Fall After $10M Equity Raise
Enveric Biosciences Inc (NASDAQ: ENVB) has priced its previously announced underwritten public offering of 20 million shares and warrants to purchase up to 20 million shares at a
12 Health Care Stocks Moving In Thursday’s After-Market Session
Gainers
Avenue Therapeutics (NASDAQ:ATXI) stock increased by 17.2% to $0.7 during Thursday's after-market session. The company's market cap stands at $14.5 million.
Benzinga’s Unprecedented Psychedelics Investing Conference Lands In Miami On April 19th
The first Benzinga Psychedelics Capital Conference, the premier gathering of psychedelics industry leaders and forward-thinking investors, is coming to the Fontainebleau Miami Beach on April 19, 2022, in Miami, Florida.